Results 111 to 120 of about 1,826,857 (351)
Rate responsive dual chamber pacing
We report about a new pacemaker, which simultaneously offers dual chamber pacing in DDD Mode and activity controlled rate response. The system also uses activity-sensing to differentiate true sinus tachycardia from ectopic atrial activity or atrial ...
Herpers, L., Kappenberger, L. J.
core +1 more source
ABSTRACT Human atrial chambers derive from distinct embryonic anlagens, the original embryonic atria gradually transforming into the so‐called auricles, or atrial appendages. This study quantifies macroscopic variations in pectinate muscle architecture in human atrial appendages and evaluates their visualization using clinical imaging modalities.
Markéta Lexová +11 more
wiley +1 more source
Trends in Cardiac Pacemaker Batteries
Batteries used in Implantable cardiac pacemakers-present unique challenges to their developers and manufacturers in terms of high levels of safety and reliability.
Ilankumaran, V +5 more
core
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger +7 more
wiley +1 more source
Cardiac Pacing and Device Therapy
Cardiac pacing is one of the best examples where the developments in technology and the microchip industry have resulted in outstanding clinical benefits to patients, and it is likely that further innovation and miniaturization will continue to make this
Ramsdale, David R., Rao, Archana
core +1 more source
Canada's 2009 risk management plan (RMP) framework has not been evaluated for prenatal exposure impact. Conversely, widely used drugs such as nonsteroidal anti‐inflammatory drugs (NSAIDs) lack RMPs. We assessed first‐trimester exposure to RMP‐regulated medications following regulatory interventions and to NSAIDs following safety publications.
Nahiyan Saiyara Khan +4 more
wiley +1 more source
Background: The high prevalence and mortality rate of combined atrial fibrillation (AF) and obstructive sleep apnea syndrome (OSAS) impose a significant disease burden on public healthcare systems. However, there is currently a lack of
Xiaoting Zhang +4 more
doaj +1 more source
BACKGROUND: Hypertrophic cardiomyopathy carries an increased risk for sudden cardiac death. While pacing therapy reduces the left ventricular outflow tract gradient and improves symptoms in a subgroup of hypertrophic obstructive cardiomyopathy (HOCM ...
Nowinski, K. +4 more
core
Atrial arrhythmias in dual chamber pacing and their influence on long-term mortality
A retrospective study of 252 patients who received a DDD pacemaker between October 1982 and December 1990 was performed. During a mean follow-up of 30 months, reprogramming to the VVI mode was necessary in 39 patients (15.5%).
Jordaens, Luc8010004320129190147966450000-0002-1407-7186840CCF1E-2AE5-11E3-A4E0-796A10BDE39D +6 more
core +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source

